Biotechnology
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.

$4.8M

Market Cap • 4/3/2025

2004

(21 years)

Founded

2024

(1 year ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Omaha

Headquarters • Nebraska